DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - DRIO ranking 11 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by linearity 10 years
1. Neogen NEOG
263.53
2. Guardant Health GH
52.73
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Inotiv NOTV
30.17
5. Illumina ILMN
10.88
6. Olink Holding OLK
8.11
7. Pacific Biosciences of California PACB
6.61
8. Myriad Genetics MYGN
5.92
9. Global Cord Blood CO
5.67
10. National Research NRC
5.44
11. DarioHealth DRIO
4.86
12. Sera Prognostics SERA
4.51
13. Sotera Health SHC
4.11
14. Syneos Health SYNH
3.71
15. Anixa Biosciences ANIX
3.45
16. Co-Diagnostics CODX
3.25
17. Enzo Biochem ENZ
2.94
18. Psychemedics PMD
2.87
19. Fulgent Genetics FLGT
2.79
20. Twist Bioscience TWST
2.64
21. Bioventus BVS
2.55
22. Qiagen QGEN
2.48
23. CareDx CDNA
2.41
24. Aspira Womens Health AWH
2.28
25. Exagen XGN
2.2
26. MDxHealth MDXH
2.15
27. Meridian Bioscience VIVO
2.1
28. Biodesix BDSX
2.03
29. MaxCyte MXCT
1.97
30. Exact Sciences EXAS
1.95
31. NeoGenomics NEO
1.91
32. Personalis PSNL
1.86
33. Prenetics Global PRE
1.86
34. bioAffinity Technologies BIAF
1.77
35. Organovo Holdings ONVO
1.66
36. Neuronetics STIM
1.64
37. Trinity Biotech TRIB
1.6
38. SeqLL SQL
1.48
39. Quest Diagnostics DGX
1.42
40. Interpace Biosciences IDXG
1.17
41. Laboratory Corp of America Holdings LH
1.16
42. PerkinElmer PKI
1.15
43. Precipio PRPO
1.09
44. DexCom DXCM
1.04
45. Charles River Laboratories CRL
0.88
46. Waters WAT
0.86
47. Agilent Technologies A
0.78
48. IQVIA Holdings IQV
0.57
49. Heska HSKA
0.52
50. IDEXX Laboratories IDXX
0.46
51. Mettler-Toledo MTD
0.42
52. Natera NTRA
0.42
53. Lantheus Holdings LNTH
0.37
54. RadNet RDNT
0.35
55. Thermo Fisher Scientific TMO
0.35
56. Danaher DHR
0.29
57. Medpace Holdings MEDP
0.29
58. Icon ICLR
0.22

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.